Intellectual Property Watch: Expanding Access To Medicines: What Role For Transparency?
“…On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into [questions about transparency and accountability in global health] at a panel co-sponsored by the Graduate Institute [Global Health Centre] and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. … [D]iscussion quickly focused in on the role and responsibilities of the pharmaceutical industry…” (Pillinger, 5/25).